Current Law Journal Content
Washington & Lee Law School
  Current Law Journal Content
                  an index to legal periodicals
 


  Bio-Science Law Review   (United Kingdom)
  Volume 5, Issue 3, 2001/2002
  homepage                   other issues
 
  • PATENTING AND ETHICS: A DUBIOUS CONNECTION
        R. Stephen Crespi
        p.71                                                                                        +cite        
        The author discusses the views on patenting as expressed first by the Nuffield Council's The Ethics of Patenting DNA and second in the Opinion of the European Group of Ethical Advisers to the European Commission (EGE) on the subject of patenting inventions involving human stem cells.
  • REGULATORY DATA PROTECTION OF MEDICINAL PRODUCTS IN EUROPE
        Trevor Cook
        p.79                                                                                        +cite        
        European Community law as to medicinal products can be traced back nearly 40 years. This article discusses the law in Europe as to regulatory data protection for pharmaceuticals both as it currently stands and as it has been proposed that it be amended.
  • FARMERS' RIGHT OR PRIVILEGE?
        Dr. Mike Adcock
        p.90                                                                                        +cite        
        India is home to a rich variety of genetic resources. The Indian Government has stated that what is an "effective" system of plant variety protection (as required by TRIPS) should be determined nationally and not in international forums. The UPOV Convention 1991 meets the needs of plant breeders but not traditional and subsistence farmers. The author studies the legislation and concludes that farmers' rights are not an intellectual property right, but they need to be viewed as an important counterbalance to the rights accorded to breeders in the formal sector under plant variety protection or patent.
  • DEVELOPMENTS IN EU LAW ON PARALLEL IMPORTS OF PHARMACEUTICALS
        Isabel Britton
        p.94                                                                                        +cite        
        A case study of Case C-172/00, Ferring Arzneimittel GmbH v. Eurim-Pharm Arznemittel GmbH, which concerns the replacement of a product on the German market with a new version, and Case C-433/00, Aventis Pharma Deutschland GmbH v. Kohlpharma GmbH, which concerns the European legislation for granting marketing authorisations through the European Agency for the Evaluation of Medicinal Products (EMEA)
  • A TEST TOO FAR? A CRITICAL ANALYSIS OF THE (NON-)PATENTABILTY OF DIAGNOSTIC METHODS AND CONSEQUENCES FOR BRCA1 GENE TYPE PATENTS IN EUROPE
        Sven J. R. Bostyn
        p.111                                                                                      +cite        
        The author analyses the BRCA1 gene patents in the light of growing concern about scientific research and affordability of the healthcare system, and comments on a number of issues presented by these patents. These are the question of patentability of this type of diagnostic method, the scope of protection claimed, the price level of the diagnostic methods and access to the patented information for research and commercial purposes.